Possible roles of epigenetics in stem cell therapy for Parkinson's disease.
Parkinson’s disease
epigenetics
methylation
stem cell therapy
stem cell transplantations
stem cells
Journal
Epigenomics
ISSN: 1750-192X
Titre abrégé: Epigenomics
Pays: England
ID NLM: 101519720
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
pubmed:
13
5
2020
medline:
27
8
2021
entrez:
13
5
2020
Statut:
ppublish
Résumé
Parkinson's disease (PD) is a neurodegenerative disease with loss of dopaminergic neurons. PD has genetic and epigenetic influences that determine specific changes in the brain. Epigenetic changes result in defective methylation of genes leading to differential gene-expression causing PD. This review provides an overview of stem cell transplantations as potential therapies for PD, with a focus on the epigenetic changes, prior or following transplantation. To date, no reports have addressed epigenetic alterations following stem cell transplantation into the PD brain. Given the potential for affecting the efficacy of stem cell therapy, increased attention needs to be given to the epigenetic processes that occur during stem cell culture and transplantation to maximize the therapeutic potential of stem cells to PD.
Identifiants
pubmed: 32396465
doi: 10.2217/epi-2019-0347
doi:
Substances chimiques
Histones
0
RNA, Long Noncoding
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM